No Change in Cancer Care 'Race Gap' S...( To learn more about cancer and cance...),Health
Navigation Links
No Change in Cancer Care 'Race Gap' Since 1990s
Date:1/7/2008
To learn more about cancer and cancer care, visit the American Cancer Society.
-- Madeline Vann
SOURCE: Cancer, news release, Jan. 2, 2008
'/>"/>
| Copyright©2008 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
2. Torchmark Corporation Announces Change in Domicile State of Insurance Subsidiaries to Nebraska
3. RxElite Registration Statement Declared Effective by Securities and Exchange Commission
4. URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs
5. Significant changes in plastic surgery expected in 2008
6. Standard & Poors Announces Changes to U.S. Indices
7. Fish Give Clues to Human Skin Color Changes
8. Smoke Free Illinois is a Positive Change
9. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
10. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
11. New Data From Shared Health, Inc., Proves Effectiveness of Health Information Exchange for Improving Patient Outcomes at the Point of Care
Post Your Comments:
(Date:1/9/2009)...Inc., Horsham, PA announced that a new Hydrophili...ed to the company,s website that provides a forum ...an go to find the latest developments in device co...d coatings news. , Horsha...rsham, PA announced that a new Hydrophilic Coatin...
(Date:1/9/2009)...nd Peptide, a Massachusetts-based designer and pro... for drug and vaccine discovery organizations worl...mical solutions in the face of the global shortage...trategic usage of new solutions are two leading pe...dges. , Gardner, MA (PRWE...
(Date:1/9/2009)...re/ -- , - New Online Service Provides the ...s at Whatever Age , A new website has been ...esigned specifically to get rid of all examination...AID and it can be found at, http://www.befreefrom...struction, there and then, on how to get rid of ex...
(Date:1/8/2009)...stCall/ - Med-Emerg International Inc. (OTCBB:MDER...of health services, is pleased to announce that it...sly announced plan of arrangement (the "Arrangemen...l meeting of MedEmerg,s shareholders held in Toron...e meeting were in favour of the Arrangement. , Th...
Breaking Medicine News(10 mins):Health News:Blog Launched to Discuss Developments in Hydrophilic Coatings for Medical Devices 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 3Health News:Be Free From Exam Nerves 2Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2[0] Blog Launched to Discuss Developments in Hydrophilic Coatings for Medical Devices[0] New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives[1] Be Free From Exam Nerves[0] Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc.
...n scientist at the US Department of Energys Oak Na...to determine to what extent there is a connection ...odel allows climatologists to relate extremes of a...year rainfall at two locations or two time periods...
...new study by researchers in National Institutes of...cal signs of dementia increases with the number of.... Among their findings is the observation that th... cerebral infarcts (strokes) is the most common mi...
14th of June is celebrated universally as the World Blood Donor Day was initiated,
...aimed that cod liver oil might help keep depressio...d University Hospital in Bergen, Norway has come ...cod liver oil, omega-3 fatty acids. The research w...habits and health of about 22,000 subjects aged 40...
Other Medicine News:Health News:Indo-American Develops Model Linking Human Activity to Climate Change 2Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Blood Donor Day 2(Date:1/8/2009)... LEUVEN, Belgium, January 9 /PRNewswire-FirstCall/...tudied in the Treatment of,Vitreomacular Adhesion...uronext Brussels: THR), a biotechnology company,f...ascular disease and,cancer, announces today that ...microplasmin for the non-surgical treatment of bac...
(Date:1/8/2009)...ney transplantation to be Quark,s second indicatio...iRNA product candidate , , FREMONT, Calif., Ja...a development-stage pharmaceutical company discove...based therapeutics, today announced that it has in...trial evaluating its systemically administered siR...
(Date:1/8/2009)...Southwestern to Identify and Validate Novel Gene E...h Innovative Gene Expression Platform , , FREMO...Gen Biosystems, Inc. (OTC Bulletin Board: WGBS), a...sion, genotyping, cell biology and stem cell resea...arch collaboration with the University of Texas S...
(Date:1/8/2009)... CHICAGO, Jan. 8 If you are taking...y, you,re not alone. Half of the people taking,pr...he reasons are,varied -- they forget, are busy wi... not to. Noncompliance has been called the Achille...neral Everett Koop commented, "Drugs don,t,work i...
Breaking Medicine Technology:ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Neanderthal bearing teeth 7498 1Neanderthal bearing teeth 7498 2Winter Brings Pet Hazards 7495 1Winter Brings Pet Hazards 7495 2Christopher Reeve Honored as Heroes Hero By CNN 7491 1Christopher Reeve Honored as Heroes Hero By CNN 7491 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 1Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 3Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 4[0] ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease[0] Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function[0] WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System[0] Good Medicine: Smarter Smartphones for People With Chronic Disease
...-Mar 26, 2007 - A study comparing,the formulations...YD) used in V-HeFT I and V-HeFT II, and BiDil, the...frican American Heart Failure,Trial (A-HeFT) demon...he formulations used may explain why V-HeFT I and ...ing mortality. Using,identical amounts of active d...
...2007 /PRNewswire/ -- DiObex,Inc., a privately- he...pment of therapeutics to treat metabolic diseases,...- 902, a novel Cortisol,Synthesis Inhibitor. , In ...cebo-controlled trial, patients with type 2 diabet...ty, pharmacokinetics and,activity of three dose le...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |